![[Article Title]](https://media.americanpharmaceuticalreview.com/m/28/article/621165-134x100.jpg)
iPSC-derived cells provide a valuable tool for disease modelling, with the ability to use cells directly from affected patients, and the potential to drive these cells towards multiple lineages. In this study, motor neurons and microglia from the same healthy and ALS iPSCs were shown to exhibit disease phenotypes which can be quantified and used for future drug discovery.